An interventional study of Telephone counseling in Type 2 Diabetes Mellitus, sponsored by German Cancer Research Center. Completed at 37 sites in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2013-12-11.
Sponsored by German Cancer Research Center · Not applicable, Interventional, and Prevention
Patients with type-2 diabetes mellitus have an higher risk developing secondary disorders. In an epidemiological longitudinal study of about 1.150 patients with type 2 diabetes mellitus we investigate determinants and predictors for long-term prognosis. The patients are recruited and supervised in practices of general practitioners of the administrative district of Ludwigsburg/Heilbronn (Baden-Württemberg, Germany). In a subgroup of about 200 patients with a dissatisfactory metabolic status (HbA1c > 7,5%) a randomised interventional study is performed. The intervention comprises a telephone counseling by the medical secretary of each practice executed in a predefined period of time. The outcome parameters of interest are the change of HbA1c, the development of secondary disorders and adverse events, quality of life and risk factor control, as well as hospitalization and mortality.
The aim of the study was to develop an patient-centred instrument implementable in the routine medical care in order to enhance the prognosis of patients with type-2 diabetes mellitus.
10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.
This study's enrollment of 204 is above the median of 80 across 8,367 interventional studies indexed under Diabetes Mellitus.
Browse Diabetes Mellitus studies →German Cancer Research Center is the lead sponsor of 46 studies on the registry; 11 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
No telephone counseling + usual care
Telephone counseling + usual care
Other: Telephone counseling
Telephone counseling is provided once a month by the medical secretary of the general practitioner's practices
HbA1c
Time frame: 18 months
hospitalization
Time frame: 18 month
CHD, mortality
Time frame: 18 months
lipid metabolism control
Time frame: 18 months
risk factor control (eg. body weight, physical activity, smoking)
Time frame: 18 months
health-related quality of life
Time frame: 18 months
incidence of diabetes-related complications
Time frame: 18 months
This study is completed, as verified in Dec 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
German Cancer Research Center